Patent 7556794 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on July, 2009 by the United States Patent and Trademark Office.
The disclosure provides pendant fatty acid compounds for use in diagnostic imaging, (particularly the cardiovascular system), as well as kits comprised of the same. The disclosure also provides for a method administering a imaging agent with a high specificity for the myocardium.